BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 28764808)

  • 1. Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
    Yang WJ; Wang MY; Pan FZ; Shi C; Cen H
    World J Surg Oncol; 2017 Aug; 15(1):144. PubMed ID: 28764808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.
    Zhou C; Luo Q; Qing Y; Lin X; Zhan Y; Ouyang M
    Tumour Biol; 2013 Dec; 34(6):3449-55. PubMed ID: 23943394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between myeloperoxidase 463G>A polymorphisms and risk of lung cancer in East-Asia population.
    Hou X; Gao Y; Duan Y; Wang Z; Shi L; Ma J; Xie X
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C97-100. PubMed ID: 26323935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
    Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
    Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects.
    Li YY; Wang H; Qian J; Kim HJ; Wu JJ; Wang LS; Zhou CW; Yang ZJ; Lu XZ
    Medicine (Baltimore); 2017 Mar; 96(12):e6461. PubMed ID: 28328864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies.
    Yang JP; Wang WB; Yang XX; Yang L; Ren L; Zhou FX; Hu L; He W; Li BY; Zhu Y; Jiang HG; Zhou YF
    PLoS One; 2013; 8(6):e65778. PubMed ID: 23840365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.
    Chang C; Gao B; Liu Z; Mao J; Jiang G
    Clin Biochem; 2013 Nov; 46(16-17):1644-8. PubMed ID: 24036021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis.
    Wang Y; Chen XY; Wang K; Li S; Zhang XY
    Medicine (Baltimore); 2017 Jul; 96(27):e7280. PubMed ID: 28682877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.
    Xu LL; Liu G; Miller DP; Zhou W; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1555-9. PubMed ID: 12496043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between MPO-463G > A polymorphism and chronic kidney disease: a meta-analysis.
    Qin J; Xing J; Li W; Zhang K; Wu Z
    Ren Fail; 2018 Nov; 40(1):541-546. PubMed ID: 30278820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma.
    Roszak A; Lutkowska A; Lianeri M; Sowińska A; Jagodziński PP
    Int J Biol Markers; 2016 Dec; 31(4):e440-e445. PubMed ID: 27197583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
    Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
    Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children.
    Weng KP; Hsieh KS; Huang SH; Wu HW; Chien JH; Lin CC; Tang CW; Ou SF; Huang SJ; Ger LP
    J Microbiol Immunol Infect; 2016 Oct; 49(5):788-796. PubMed ID: 26066543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
    Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
    Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription Factor 7-Like 2 (TCF7L2) rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis.
    Lin PC; Lin WT; Yeh YH; Wung SF
    PLoS One; 2016; 11(4):e0153044. PubMed ID: 27058589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of -463G/A MPO gene polymorphism and risk of cervical intraepithelial neoplasia.
    Natter C; Polterauer S; Pils S; Castillo-Tong DC; Zeilinger R; Heinze G; Hefler L; Grimm C
    Arch Gynecol Obstet; 2016 Apr; 293(4):865-9. PubMed ID: 26319155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase -463 G/A polymorphism is associated with lung cancer risk: A meta-analysis with 7420 cases and 9132 controls.
    Zou S; Pan X; Hua C; Wu M; He B; Chen Z
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S282-S287. PubMed ID: 29970677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
    Polonikov AV; Solodilova MA; Ivanov VP
    J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase G463A polymorphism and lung cancer risk in Asians: a pooled analysis.
    Zhou YY; Zhang SM; Cai ZG; Zhang H; Wang L; Xu XP; Wu HB
    Tumour Biol; 2013 Oct; 34(5):3035-9. PubMed ID: 23832536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk.
    Jiang Z; Zhang Z; Wang Z; Zhang G; Hu K; He B; Wang S
    Hepatogastroenterology; 2012 May; 59(115):757-61. PubMed ID: 22094928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.